Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Healthpeak Properties jumps 15% after Q1 beat and higher 2026 outlook tied to Janus Living IPO

None

Healthpeak Properties, Inc. (DOC) is up 15.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is Healthpeak’s first-quarter 2026 results and a higher full-year 2026 outlook, alongside investor enthusiasm for the recently completed Janus Living IPO and related capital allocation plans. The combination of an earnings beat and improved forward expectations can quickly re-rate a REIT when the market was positioned cautiously.

Details:

  • Healthpeak released first-quarter 2026 results and discussed performance across its healthcare real estate portfolio, alongside an updated full-year 2026 outlook.
  • The company raised its 2026 FFO guidance range, signaling improved expected earnings power versus its prior outlook.
  • Healthpeak highlighted the completion of the Janus Living IPO and its continuing majority ownership stake, which investors may view as improving strategic flexibility and funding capacity for acquisitions.
  • Management also framed recent actions as “accretive” capital allocation, which can support sentiment when paired with solid quarterly execution.
  • Sources:

    Healthpeak Properties Investor Relations, SEC, Finviz

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    EARLY ACCESS
    Receive DOC Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $DOC Hedge Fund Activity

    We have seen 360 institutional investors add shares of $DOC stock to their portfolio, and 358 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

    $DOC Congressional Stock Trading

    Members of Congress have traded $DOC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $DOC stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

    $DOC Price Targets

    Multiple analysts have issued price targets for $DOC recently. We have seen 8 analysts offer price targets for $DOC in the last 6 months, with a median target of $17.75.

    Here are some recent targets:

    • Richard Hill from Morgan Stanley set a target price of $18.0 on 04/28/2026
    • An analyst from UBS set a target price of $17.0 on 04/20/2026
    • Amanda Sweitzer from Baird set a target price of $19.0 on 04/06/2026
    • Nick Joseph from Citigroup set a target price of $17.5 on 04/01/2026
    • James Kammert from Evercore ISI Group set a target price of $19.0 on 02/04/2026
    • John Kilichowski from Wells Fargo set a target price of $18.0 on 02/02/2026
    • Julien Blouin from Goldman Sachs set a target price of $17.0 on 01/09/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles